{
    "info": {
        "nct_id": "NCT04944901",
        "official_title": "Randomized, Double-blind, Placebo-controlled, 28-Day Daily-dose Crossover Study of the Safety and Tolerability of SB-121 (Lactobacillus Reuteri With Sephadex® and Maltose) in Subjects, Ages 15 to 45 Years, Diagnosed With Autistic Disorder",
        "inclusion_criteria": "* Subject/parent (or authorized designee) has provided written informed consent for the study.\n* Subject is ≥15 and ≤45 years of age at the time of enrollment.\n* Diagnosis of autistic disorder (AD) as confirmed by the gold standard clinical interview using Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 criteria and administration of the Autism Diagnostic Observation Schedule-2.\n* Subject, if female and of childbearing potential, is not lactating or pregnant.\n* Subject, if female, is either not of childbearing potential or is practicing an acceptable effective method of birth control.\n* Subject is willing to comply with all study requirements (including the requirements for stool sampling and biobanking) and to return to the study facility for the follow-up evaluations, as required.\nHealthy volunteers allowed\nMust have minimum age of 15 Years\nMust have maximum age of 45 Years",
        "exclusion_criteria": "* Subject has known allergy or significant adverse reaction to L reuteri, Sephadex®, maltose, or related compounds.\n* Subject has previously had GI surgery, intestinal obstruction, Clostridium difficile infection or diverticulitis.\n* Subject has travelled outside of the USA in the 30 days prior to screening.\n* Subject has had a diarrheal illness in 30 days prior to screening.\n* Subject currently has a fever or active/uncontrolled gastrointestinal (GI) symptoms (e.g., nausea, vomiting, diarrhea, constipation, abdominal distention, abdominal pain/cramps, flatulence) or has had these within 14 days prior to screening. If the GI symptoms are stable, in the opinion of the investigator, the subject can be enrolled.\n* Subject has any immunological/autoimmune disorder including, but not limited to, systemic lupus erythematosis, rheumatoid arthritis, Sjögren's syndrome, inflammatory bowel disease, or immunoglobulin-deficiency disorder, that would increase the risk to the subject or interfere with the evaluation of SB-121.\n* Subject has a documented history of human immunodeficiency virus (HIV), hepatitis B and/or hepatitis C\n* Subject has implanted prosthetic devices including prosthetic heart valves.\n* Subject has taken, or is taking, any of the following prohibited medications:\n\n  1. A proton pump inhibitor within 2 weeks prior to screening\n  2. Use of supplemental probiotics within 2 weeks prior to screening except for yogurt\n  3. Current use of immunosuppressive medications, including corticosteroids\n  4. Treatment with monoclonal antibodies within 4 weeks prior to screening\n  5. Systemic antibiotics within 2 weeks prior to screening\n* Subject has diabetes mellitus or is prediabetic.\n* Subject has received any IP (or investigational device) within 30 days prior to screening.\n* Subject has any of the following laboratory test results at Screening:\n\n  1. An absolute neutrophil count of <1.5 × 10^9/L\n  2. alanine aminotransferase or aspartate aminotransferase >1.5 × upper limit normal (ULN), total bilirubin >1.5 × ULN (subjects with known Gilbert's Syndrome can be included)\n  3. serum creatinine >1.5 × ULN\n  4. any other abnormal laboratory test that is clinically significant in the judgment of the investigator.\n* Subject has an unstable medical condition or is otherwise considered unreliable or incapable, in the opinion of the investigator, of complying with the requirements of the protocol.\n* Subject tests positive for drugs of abuse in a urine drug screen at screening.\n* Subject has a history of alcohol abuse.",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have maximum age of 45 Years",
            "criterions": [
                {
                    "exact_snippets": "maximum age of 45 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "maximum",
                            "expected_value": {
                                "operator": "<=",
                                "value": 45,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 15 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 15 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 15,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subject, if female, is either not of childbearing potential or is practicing an acceptable effective method of birth control.",
            "criterions": [
                {
                    "exact_snippets": "Subject, if female, is either not of childbearing potential",
                    "criterion": "childbearing potential (female subjects)",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": "not of childbearing potential"
                        }
                    ]
                },
                {
                    "exact_snippets": "Subject, if female, ... is practicing an acceptable effective method of birth control",
                    "criterion": "birth control method (female subjects)",
                    "requirements": [
                        {
                            "requirement_type": "method",
                            "expected_value": "acceptable effective method of birth control"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subject is ≥15 and ≤45 years of age at the time of enrollment.",
            "criterions": [
                {
                    "exact_snippets": "Subject is ≥15 and ≤45 years of age at the time of enrollment.",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "age at enrollment",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 15,
                                        "unit": "years"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 45,
                                        "unit": "years"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subject is willing to comply with all study requirements (including the requirements for stool sampling and biobanking) and to return to the study facility for the follow-up evaluations, as required.",
            "criterions": [
                {
                    "exact_snippets": "Subject is willing to comply with all study requirements",
                    "criterion": "willingness to comply with study requirements",
                    "requirements": [
                        {
                            "requirement_type": "willingness",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "including the requirements for stool sampling and biobanking",
                    "criterion": "willingness to comply with stool sampling and biobanking",
                    "requirements": [
                        {
                            "requirement_type": "willingness",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "to return to the study facility for the follow-up evaluations, as required",
                    "criterion": "willingness to return for follow-up evaluations",
                    "requirements": [
                        {
                            "requirement_type": "willingness",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subject, if female and of childbearing potential, is not lactating or pregnant.",
            "criterions": [
                {
                    "exact_snippets": "if female and of childbearing potential",
                    "criterion": "sex and childbearing potential",
                    "requirements": [
                        {
                            "requirement_type": "sex",
                            "expected_value": "female"
                        },
                        {
                            "requirement_type": "childbearing potential",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "is not lactating",
                    "criterion": "lactation status",
                    "requirements": [
                        {
                            "requirement_type": "lactating",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "is not ... pregnant",
                    "criterion": "pregnancy status",
                    "requirements": [
                        {
                            "requirement_type": "pregnant",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Diagnosis of autistic disorder (AD) as confirmed by the gold standard clinical interview using Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 criteria and administration of the Autism Diagnostic Observation Schedule-2.",
            "criterions": [
                {
                    "exact_snippets": "Diagnosis of autistic disorder (AD)",
                    "criterion": "autistic disorder diagnosis",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "as confirmed by the gold standard clinical interview using Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 criteria",
                    "criterion": "DSM-5 criteria for autistic disorder",
                    "requirements": [
                        {
                            "requirement_type": "confirmation",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "administration of the Autism Diagnostic Observation Schedule-2",
                    "criterion": "Autism Diagnostic Observation Schedule-2 administration",
                    "requirements": [
                        {
                            "requirement_type": "administration",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subject/parent (or authorized designee) has provided written informed consent for the study.",
            "criterions": [
                {
                    "exact_snippets": "Subject/parent (or authorized designee) has provided written informed consent for the study.",
                    "criterion": "written informed consent",
                    "requirements": [
                        {
                            "requirement_type": "provision",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "* Subject has travelled outside of the USA in the 30 days prior to screening.",
            "criterions": [
                {
                    "exact_snippets": "Subject has travelled outside of the USA in the 30 days prior to screening.",
                    "criterion": "travel outside of the USA",
                    "requirements": [
                        {
                            "requirement_type": "recency",
                            "expected_value": {
                                "operator": "<=",
                                "value": 30,
                                "unit": "days"
                            }
                        },
                        {
                            "requirement_type": "time_reference",
                            "expected_value": "prior to screening"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subject has taken, or is taking, any of the following prohibited medications:",
            "criterions": [
                {
                    "exact_snippets": "Subject has taken, or is taking, any of the following prohibited medications",
                    "criterion": "use of prohibited medications",
                    "requirements": [
                        {
                            "requirement_type": "exposure",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subject has diabetes mellitus or is prediabetic.",
            "criterions": [
                {
                    "exact_snippets": "Subject has diabetes mellitus",
                    "criterion": "diabetes mellitus",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "is prediabetic",
                    "criterion": "prediabetes",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "4. Treatment with monoclonal antibodies within 4 weeks prior to screening",
            "criterions": [
                {
                    "exact_snippets": "Treatment with monoclonal antibodies within 4 weeks prior to screening",
                    "criterion": "treatment with monoclonal antibodies",
                    "requirements": [
                        {
                            "requirement_type": "recency",
                            "expected_value": {
                                "operator": "<=",
                                "value": 4,
                                "unit": "weeks prior to screening"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "3. Current use of immunosuppressive medications, including corticosteroids",
            "criterions": [
                {
                    "exact_snippets": "Current use of immunosuppressive medications",
                    "criterion": "immunosuppressive medication use",
                    "requirements": [
                        {
                            "requirement_type": "current use",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "including corticosteroids",
                    "criterion": "corticosteroid use",
                    "requirements": [
                        {
                            "requirement_type": "current use",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "5. Systemic antibiotics within 2 weeks prior to screening",
            "criterions": [
                {
                    "exact_snippets": "Systemic antibiotics within 2 weeks prior to screening",
                    "criterion": "systemic antibiotic use",
                    "requirements": [
                        {
                            "requirement_type": "time since last use",
                            "expected_value": {
                                "operator": ">=",
                                "value": 2,
                                "unit": "weeks"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "3. serum creatinine >1.5 × ULN",
            "criterions": [
                {
                    "exact_snippets": "serum creatinine >1.5 × ULN",
                    "criterion": "serum creatinine",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 1.5,
                                "unit": "ULN"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subject has a history of alcohol abuse.",
            "criterions": [
                {
                    "exact_snippets": "history of alcohol abuse",
                    "criterion": "alcohol abuse",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subject has had a diarrheal illness in 30 days prior to screening.",
            "criterions": [
                {
                    "exact_snippets": "Subject has had a diarrheal illness in 30 days prior to screening.",
                    "criterion": "diarrheal illness",
                    "requirements": [
                        {
                            "requirement_type": "presence_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 30,
                                "unit": "days prior to screening"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. An absolute neutrophil count of <1.5 × 10^9/L",
            "criterions": [
                {
                    "exact_snippets": "An absolute neutrophil count of <1.5 × 10^9/L",
                    "criterion": "absolute neutrophil count",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 1.5,
                                "unit": "× 10^9/L"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subject has implanted prosthetic devices including prosthetic heart valves.",
            "criterions": [
                {
                    "exact_snippets": "implanted prosthetic devices",
                    "criterion": "implanted prosthetic devices",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "prosthetic heart valves",
                    "criterion": "prosthetic heart valves",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subject currently has a fever or active/uncontrolled gastrointestinal (GI) symptoms (e.g., nausea, vomiting, diarrhea, constipation, abdominal distention, abdominal pain/cramps, flatulence) or has had these within 14 days prior to screening. If the GI symptoms are stable, in the opinion of the investigator, the subject can be enrolled.",
            "criterions": [
                {
                    "exact_snippets": "Subject currently has a fever",
                    "criterion": "fever",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "active/uncontrolled gastrointestinal (GI) symptoms (e.g., nausea, vomiting, diarrhea, constipation, abdominal distention, abdominal pain/cramps, flatulence)",
                    "criterion": "gastrointestinal symptoms",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": "active or uncontrolled"
                        }
                    ]
                },
                {
                    "exact_snippets": "has had these within 14 days prior to screening",
                    "criterion": "gastrointestinal symptoms",
                    "requirements": [
                        {
                            "requirement_type": "history_within_days",
                            "expected_value": {
                                "operator": "<=",
                                "value": 14,
                                "unit": "days"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subject has a documented history of human immunodeficiency virus (HIV), hepatitis B and/or hepatitis C",
            "criterions": [
                {
                    "exact_snippets": "documented history of human immunodeficiency virus (HIV)",
                    "criterion": "human immunodeficiency virus (HIV) infection",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "documentation",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "documented history of ... hepatitis B",
                    "criterion": "hepatitis B infection",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "documentation",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "documented history of ... hepatitis C",
                    "criterion": "hepatitis C infection",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "documentation",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. A proton pump inhibitor within 2 weeks prior to screening",
            "criterions": [
                {
                    "exact_snippets": "A proton pump inhibitor within 2 weeks prior to screening",
                    "criterion": "proton pump inhibitor use",
                    "requirements": [
                        {
                            "requirement_type": "time since last use",
                            "expected_value": {
                                "operator": ">=",
                                "value": 2,
                                "unit": "weeks"
                            }
                        },
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. Use of supplemental probiotics within 2 weeks prior to screening except for yogurt",
            "criterions": [
                {
                    "exact_snippets": "Use of supplemental probiotics within 2 weeks prior to screening except for yogurt",
                    "criterion": "use of supplemental probiotics",
                    "requirements": [
                        {
                            "requirement_type": "time since last use",
                            "expected_value": {
                                "operator": ">=",
                                "value": 2,
                                "unit": "weeks"
                            }
                        },
                        {
                            "requirement_type": "exception",
                            "expected_value": "yogurt"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subject has previously had GI surgery, intestinal obstruction, Clostridium difficile infection or diverticulitis.",
            "criterions": [
                {
                    "exact_snippets": "previously had GI surgery",
                    "criterion": "GI surgery",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "intestinal obstruction",
                    "criterion": "intestinal obstruction",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Clostridium difficile infection",
                    "criterion": "Clostridium difficile infection",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "diverticulitis",
                    "criterion": "diverticulitis",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subject tests positive for drugs of abuse in a urine drug screen at screening.",
            "criterions": [
                {
                    "exact_snippets": "tests positive for drugs of abuse in a urine drug screen at screening",
                    "criterion": "drugs of abuse in urine drug screen",
                    "requirements": [
                        {
                            "requirement_type": "test result",
                            "expected_value": "positive"
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": "at screening"
                        }
                    ]
                }
            ]
        },
        {
            "line": "4. any other abnormal laboratory test that is clinically significant in the judgment of the investigator.",
            "criterions": [
                {
                    "exact_snippets": "any other abnormal laboratory test that is clinically significant in the judgment of the investigator",
                    "criterion": "laboratory test result",
                    "requirements": [
                        {
                            "requirement_type": "abnormality",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "clinical significance (per investigator judgment)",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subject has any of the following laboratory test results at Screening:",
            "criterions": [
                {
                    "exact_snippets": "any of the following laboratory test results at Screening",
                    "criterion": "laboratory test results at Screening",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subject has received any IP (or investigational device) within 30 days prior to screening.",
            "criterions": [
                {
                    "exact_snippets": "Subject has received any IP (or investigational device) within 30 days prior to screening.",
                    "criterion": "receipt of investigational product or investigational device",
                    "requirements": [
                        {
                            "requirement_type": "time since receipt",
                            "expected_value": {
                                "operator": "<=",
                                "value": 30,
                                "unit": "days"
                            }
                        },
                        {
                            "requirement_type": "status",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. alanine aminotransferase or aspartate aminotransferase >1.5 × upper limit normal (ULN), total bilirubin >1.5 × ULN (subjects with known Gilbert's Syndrome can be included)",
            "criterions": [
                {
                    "exact_snippets": "alanine aminotransferase ... >1.5 × upper limit normal (ULN)",
                    "criterion": "alanine aminotransferase",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 1.5,
                                "unit": "ULN"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "aspartate aminotransferase >1.5 × upper limit normal (ULN)",
                    "criterion": "aspartate aminotransferase",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 1.5,
                                "unit": "ULN"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "total bilirubin >1.5 × ULN (subjects with known Gilbert's Syndrome can be included)",
                    "criterion": "total bilirubin",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 1.5,
                                "unit": "ULN"
                            }
                        },
                        {
                            "requirement_type": "exception",
                            "expected_value": "subjects with known Gilbert's Syndrome can be included"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subject has an unstable medical condition or is otherwise considered unreliable or incapable, in the opinion of the investigator, of complying with the requirements of the protocol.",
            "criterions": [
                {
                    "exact_snippets": "unstable medical condition",
                    "criterion": "medical condition",
                    "requirements": [
                        {
                            "requirement_type": "stability",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "unreliable or incapable, in the opinion of the investigator, of complying with the requirements of the protocol",
                    "criterion": "ability to comply with protocol requirements",
                    "requirements": [
                        {
                            "requirement_type": "capability",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "reliability",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subject has any immunological/autoimmune disorder including, but not limited to, systemic lupus erythematosis, rheumatoid arthritis, Sjögren's syndrome, inflammatory bowel disease, or immunoglobulin-deficiency disorder, that would increase the risk to the subject or interfere with the evaluation of SB-121.",
            "criterions": [
                {
                    "exact_snippets": "Subject has any immunological/autoimmune disorder including, but not limited to, systemic lupus erythematosis, rheumatoid arthritis, Sjögren's syndrome, inflammatory bowel disease, or immunoglobulin-deficiency disorder",
                    "criterion": "immunological/autoimmune disorder",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "examples",
                            "expected_value": [
                                "systemic lupus erythematosis",
                                "rheumatoid arthritis",
                                "Sjögren's syndrome",
                                "inflammatory bowel disease",
                                "immunoglobulin-deficiency disorder"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "that would increase the risk to the subject or interfere with the evaluation of SB-121",
                    "criterion": "potential risk or interference due to disorder",
                    "requirements": [
                        {
                            "requirement_type": "risk to subject or interference with evaluation",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [
        {
            "line": "* Subject has known allergy or significant adverse reaction to L reuteri, Sephadex®, maltose, or related compounds.",
            "criterions": [
                {
                    "exact_snippets": "known allergy ... to L reuteri",
                    "criterion": "allergy to L reuteri",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "known allergy ... to Sephadex®",
                    "criterion": "allergy to Sephadex®",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "known allergy ... to maltose",
                    "criterion": "allergy to maltose",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "known allergy ... to related compounds",
                    "criterion": "allergy to related compounds",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "significant adverse reaction to L reuteri",
                    "criterion": "significant adverse reaction to L reuteri",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "significant adverse reaction to Sephadex®",
                    "criterion": "significant adverse reaction to Sephadex®",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "significant adverse reaction to maltose",
                    "criterion": "significant adverse reaction to maltose",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "significant adverse reaction to related compounds",
                    "criterion": "significant adverse reaction to related compounds",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "failed_miscellaneous": []
}